Login to MyKarger

New to MyKarger? Click here to sign up.



Login with Facebook

Forgot your password?

Authors, Editors, Reviewers

For Manuscript Submission, Check or Review Login please go to Submission Websites List.

Submission Websites List

Institutional Login
(Shibboleth or Open Athens)

For the academic login, please select your country in the dropdown list. You will be redirected to verify your credentials.

Transfusion Medicine and Hemotherapy

Vol. 44, No. 5, 2017

Issue release date: October 2017

Add all to MyReading List
 
281

Editorial Board / Contents / Imprint

Transfus Med Hemother 2017;44:281-286 (DOI:10.1159/000481596)
Free Access
Editorial
288

Congress of the German Society of Transfusion Medicine and Immunohematology - 50th Anniversary

Klüter H. · Gathof B. · Schlenke P.
Transfus Med Hemother 2017;44:288-289 (DOI:10.1159/000481546)
Free Access
290

Antibody Engineering - Tailor-Made Next Generation Antibodies by Molecular Design

Humpe A. · Peipp M.
Transfus Med Hemother 2017;44:290-291 (DOI:10.1159/000479617)
Free Access
Original Article
292

An Fc Double-Engineered CD20 Antibody with Enhanced Ability to Trigger Complement-Dependent Cytotoxicity and Antibody-Dependent Cell-Mediated Cytotoxicity

Wirt T. · Rosskopf S. · Rösner T · Eichholz K.M. · Kahrs A. · Lutz S. · Kretschmer A · Valerius T · Klausz K. · Otte A. · Gramatzki M. · Peipp M · Kellner C.
Transfus Med Hemother 2017;44:292-300 (DOI:10.1159/000479978)
Free Access
Review Article
303

Human Antibody Fusion Proteins/Antibody Drug Conjugates in Breast and Ovarian Cancer

Padayachee E.R. · Biteghe F.A.N. · Malindi Z. · Bauerschlag D. · Barth S.
Transfus Med Hemother 2017;44:303-310 (DOI:10.1159/000479979)
Free Access
312

Designing Human Antibodies by Phage Display

Frenzel A. · Kügler J. · Helmsing S. · Meier D. · Schirrmann T. · Hust M. · Dübel S.
Transfus Med Hemother 2017;44:312-318 (DOI:10.1159/000479633)
Free Access
320

Antibody Isotypes for Tumor Immunotherapy

Kretschmer A. · Schwanbeck R. · Valerius T. · Rösner T.
Transfus Med Hemother 2017;44:320-326 (DOI:10.1159/000479240)
Free Access
327

Modulating Cytotoxic Effector Functions by Fc Engineering to Improve Cancer Therapy

Kellner C · Otte A · Cappuzzello E. · Klausz K · Peipp M
Transfus Med Hemother 2017;44:327-336 (DOI:10.1159/000479980)
Free Access
337

Recombinant Antibodies to Arm Cytotoxic Lymphocytes in Cancer Immunotherapy

Koch J. · Tesar M.
Transfus Med Hemother 2017;44:337-350 (DOI:10.1159/000479981)
Free Access
Original Article
351

Components in Plasma-Derived Factor VIII, But Not in Recombinant Factor VIII Downregulate Anti-Inflammatory Surface Marker CD163 in Human Macrophages through Release of CXCL4 (Platelet Factor 4)

Bertling A. · Brodde M.F. · Visser M. · Treffon J. · Fennen M. · Fender A.C. · Kelsch R. · Kehrel B.E.
Transfus Med Hemother 2017;44:351-357 (DOI:10.1159/000472157)
Free Access
358

Red Cell Genotyping by Multiplex PCR Identifies Antigen-Matched Blood Units for Transfusion-Dependent Thai Patients

Intharanut K. · Bejrachandra S. · Nathalang S. · Leetrakool N. · Nathalang O.
Transfus Med Hemother 2017;44:358-364 (DOI:10.1159/000471886)
Free Access
 
365

News

Transfus Med Hemother 2017;44:365 (DOI:10.1159/000481590)
MyKarger login required
Free Access
366

News

Transfus Med Hemother 2017;44:366-367 (DOI:10.1159/000481591)
MyKarger login required
Free Access
368

News

Transfus Med Hemother 2017;44:368 (DOI:10.1159/000481592)
MyKarger login required
Free Access
369

News

Transfus Med Hemother 2017;44:369 (DOI:10.1159/000481296)
MyKarger login required
Free Access
370

News

Transfus Med Hemother 2017;44:370-372 (DOI:10.1159/000481594)
MyKarger login required
Free Access
375

Meetings and Conferences

Transfus Med Hemother 2017;44:375-376 (DOI:10.1159/000481220)
Free Access